1Taylor BC, Yuan JM, Shamliyan TA, et al. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence. Hepatology, 2009, 49(5 Suppl): S85-95.
2Cheung O, Sanyal AJ. Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis, 2008, 12: 573-585.
3Fan JG, Chitturi S. Hepatitis B and fatty liver: causal or coincidental? J Gastroenterol Hepatol, 2008, 23: 679-681.
4Cross TJ, Quaglia A, Hughes S, et al. The impact of hepatic steato- sis on the natural history of chronic hepatitis C infection. J Viral Hepat, 2009, 16: 492-499.
5Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009, 50: 204-210.
6Shi JP, Fan JG, Wu R, et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol, 2008, 23: 1419-1425.
7Petta S, Camma C, Di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol, 2008, 103: 1136-1144.
8Tsochatzis E, Papatheodoridis GV, Hadziyannis E, et al. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol, 2008, 43:1128-1136.
9Jonsson JR, Barrie HD, O'Rourke P, et al. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C. Hepatology, 2008, 48: 80-87.
10Machado MV, Cortez-Pinto H. Insulin resistance and steatosis in chronic hepatitis C. Ann Hepatol, 2009, 8(Suppl 1): S67-75.
